(2)
Eligibility
To be eligible to receive a subgrant under paragraph (1), an entity shall—
(A)
be a local health organization, an international organization, or a partnership of such organizations; and
(B)
demonstrate to the awarding organization that such entity—
(i)
is currently administering a proven intervention to prevent mother-to-child transmission of HIV in countries with or at risk for severe HIV epidemic with particular attention to resource constrained countries, as determined by the President;
(ii)
has demonstrated support for the proposed program from relevant government entities; and
(iii)
is able to provide HIV care, including antiretroviral treatment when medically indicated, to HIV positive women, men, and children with the support of the project funding.
(3)
Local health and international organizations
For purposes of paragraph (2)(A)—
(A)
the term “local health organization” means a public sector health system, nongovernmental organization, institution of higher education, community-based organization, or nonprofit health system that provides directly, or has a clear link with a provider for the indirect provision of, primary health care services; and
(B)
the term “international organization” means—
(i)
a nonprofit international entity;
(ii)
an international charitable institution;
(iii)
a private voluntary international entity; or
(iv)
a multilateral institution.
(5)
Selection of subgrant recipients
In awarding subgrants under this subsection, the organization should—
(A)
consider applicants from a range of health care settings, program approaches, and geographic locations; and
(B)
if appropriate, award not less than 1 grant to an applicant to fund a national system of health care delivery to HIV positive families.
(6)
Use of subgrant funds
An eligible entity awarded a subgrant under this subsection shall use subgrant funds to expand activities to prevent mother-to-child transmission of HIV by providing medical treatment and care and support services to parents and their children, which may include—
(A)
providing treatment and therapy, when medically indicated, to HIV-infected women, their children, and families;
(B)
the hiring and training of local personnel, including physicians, nurses, other health care providers, counselors, social workers, outreach personnel, laboratory technicians, data managers, and administrative support personnel;
(C)
paying laboratory costs, including costs related to necessary equipment and diagnostic testing and monitoring (including rapid testing), complete blood counts, standard chemistries, and liver function testing for infants, children, and parents, and costs related to the purchase of necessary laboratory equipment;
(D)
purchasing pharmaceuticals for HIV-related conditions, including antiretroviral therapies;
(E)
funding support services, including adherence and psychosocial support services;
(F)
operational support activities; and
(G)
conducting community outreach and capacity building activities, including activities to raise the awareness of individuals of the program carried out by the subgrantee, other communications activities in support of the program, local advisory board functions, and transportation necessary to ensure program participation.